Amunix Pharmaceuticals Funding & Investors
Amunix Inc. is a pharmaceutical company. The Company focuses on therapeutic drugs which offer an alternative to antibodies and small molecules. Amunix also concentrates on protein design and the discovery research process.
amunix.comTotal Amount Raised: $190,000,000
Amunix Pharmaceuticals Funding Rounds
Series B
$117,000,000
Series B Investors
Viking Global InvestorsOmega Fund ManagementCasdin CapitalRedmile GroupVenrock Healthcare Capital PartnersAvidity Partners ManagementLongitude CapitalJanus HendersonArrowMark PartnersBlackRockCaaS Capital ManagementFranklin ResourcesPolaris PartnersBain Capital Life SciencesClough Capital PartnersFrazier ManagementSeries A
$73,000,000
Series A Investors
Omega Fund ManagementFrazier ManagementLongitude CapitalPolaris PartnersVenrockRedmile GroupBeijing Delian InvestmentCasdin CapitalTwo River
Funding info provided by Diffbot.